Ruco L - Search Results

1

Study of histopathologic parameters to define the prognosis of stage II colon cancer.

Romiti A, Roberto M, Marchetti P, Di Cerbo A, Falcone R, Campisi G, Ferri M, Balducci G, Ramacciato G, Ruco L, Pilozzi E. Romiti A, et al. Among authors: ruco l. Int J Colorectal Dis. 2019 May;34(5):905-913. doi: 10.1007/s00384-019-03279-1. Epub 2019 Mar 26. Int J Colorectal Dis. 2019. PMID: 30915540

2

Prognostic significance of 18q LOH in sporadic colorectal carcinoma.

Pilozzi E, Ferri M, Onelli MR, Mercantini P, Corigliano N, Duranti E, Dionisi L, Felicioni F, Virgilio E, Ziparo V, Ruco L. Pilozzi E, et al. Among authors: ruco l. Am Surg. 2011 Jan;77(1):38-43. Am Surg. 2011. PMID: 21396303

3

Lymph node ratio is a stronger prognostic factor than microsatellite instability in colorectal cancer patients: results from a 7 years follow-up study.

Ferri M, Lorenzon L, Onelli MR, La Torre M, Mercantini P, Virgilio E, Balducci G, Ruco L, Ziparo V, Pilozzi E. Ferri M, et al. Among authors: ruco l. Int J Surg. 2013;11(9):1016-21. doi: 10.1016/j.ijsu.2013.05.031. Epub 2013 Jun 6. Int J Surg. 2013. PMID: 23747976 Free article.

4

Left-sided early onset colorectal carcinomas: A sporadic neoplasm with aggressive behavior.

Pilozzi E, Lorenzon L, Lo Baido S, Ferri M, Duranti E, Fochetti F, Mercantini P, Ramacciato G, Balducci G, Ruco L. Pilozzi E, et al. Among authors: ruco l. Am J Surg. 2017 Sep;214(3):421-427. doi: 10.1016/j.amjsurg.2017.01.035. Epub 2017 Jan 31. Am J Surg. 2017. PMID: 28173936

5

Somatostatin receptor subtype 2 A (SSTR2A) and HER2 expression in gastric adenocarcinoma.

Romiti A, Di Rocco R, Milione M, Ruco L, Ziparo V, Zullo A, Duranti E, Sarcina I, Barucca V, D'Antonio C, Marchetti P. Romiti A, et al. Among authors: ruco l. Anticancer Res. 2012 Jan;32(1):115-9. Anticancer Res. 2012. PMID: 22213295 Clinical Trial.

6

Left-sided early-onset vs late-onset colorectal carcinoma: histologic, clinical, and molecular differences.

Pilozzi E, Maresca C, Duranti E, Giustiniani MC, Catalanotto C, Lucarelli M, Cogoni C, Ferri M, Ruco L, Zardo G. Pilozzi E, et al. Among authors: ruco l. Am J Clin Pathol. 2015 Mar;143(3):374-84. doi: 10.1309/AJCPNOC55IOLXFUD. Am J Clin Pathol. 2015. PMID: 25696795

7

Primary malignant tumour of the lung with neuroendocrine and melanoma differentiation.

Pilozzi E, Cacchi C, Di Napoli A, Pini B, Duranti E, D'Andrilli A, Ruco L. Pilozzi E, et al. Among authors: ruco l. Virchows Arch. 2011 Aug;459(2):239-43. doi: 10.1007/s00428-011-1109-7. Epub 2011 Jul 7. Virchows Arch. 2011. PMID: 21735167 No abstract available.

8

CDX1 expression is reduced in colorectal carcinoma and is associated with promoter hypermethylation.

Pilozzi E, Onelli MR, Ziparo V, Mercantini P, Ruco L. Pilozzi E, et al. Among authors: ruco l. J Pathol. 2004 Nov;204(3):289-95. doi: 10.1002/path.1641. J Pathol. 2004. PMID: 15378566

9

COX-2 is induced by HGF stimulation in Met-positive thyroid papillary carcinoma cells and is involved in tumour invasiveness.

Scarpino S, Duranti E, Stoppacciaro A, Pilozzi E, Natoli G, Sciacchitano S, Luciani E, Ruco L. Scarpino S, et al. Among authors: ruco l. J Pathol. 2009 Aug;218(4):487-94. doi: 10.1002/path.2556. J Pathol. 2009. PMID: 19391129

10

Metastatic colorectal cancer first-line treatment with bevacizumab: the impact of K-ras mutation.

Rossi L, Veltri E, Zullo A, Zoratto F, Colonna M, Longo F, Mottolese M, Giannarelli D, Ruco L, Marchetti P, Romiti A, Barucca V, Giannini G, Bianchi L, Tomao S. Rossi L, et al. Among authors: ruco l. Onco Targets Ther. 2013 Nov 29;6:1761-9. doi: 10.2147/OTT.S43828. eCollection 2013. Onco Targets Ther. 2013. PMID: 24348051 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

213 results

Search Page

Filters